Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026

WYHG vs HLF: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

HLF Wins Head-to-Head Institutional Verdict (5–1 across 6 Pillars · 7–3 Matrix Metrics)

HLF Overall Winner 6-Pillar Tally: WYHG 1 – 5 HLF Matrix Metrics: WYHG 3 – 7 HLF

As of Nov 20, 2026, Herbalife Ltd. (HLF) is the stronger overall head-to-head candidate over Wing Yip Food Holdings Group Limited (WYHG) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). WYHG carries a Unified Composite Score of 41.6/100 (SELL) at $2.62 (N/M Forward P/E, 7.8% operating margin), whereas HLF carries 47.4/100 (HOLD) at $15.53 (5.1x Forward P/E, 9.8% operating margin).

  • Technical & Structure Timing Caution: WYHG is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 40.2); meanwhile HLF trades in a Markup technical trend (SURGE options phase, RSI 59.0). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About WYHG vs HLF
WYHG NASDAQ
Wing Yip Food Holdings Group Limited American Depositary Shares
Sausages & Other Prepared Meat Products
$2.62
-6.09% 1D
Market Cap $99.3M
TTM Revenue $310M
Forward P/E N/M
Beta / 30D Vol 1.20β · 156% Vol
Unified Composite Score
41.6 / 100 SELL
Tech 30.0 Fund 38.0 Flow 50.0 Mom 50.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -17.1%), weak momentum, RSI 40
RSI-14: 40.2 · SMA20: $3.13 · SMA50: $3.40
HLF NYSE Head-to-Head Winner
Herbalife Ltd.
Wholesale-Drugs, Proprietaries & Druggists' Sundries
$15.53
-0.26% 1D
Market Cap $1.6B
TTM Revenue $5.28B
Forward P/E 5.1x
Beta / 30D Vol 1.02β · 50% Vol
Unified Composite Score
47.4 / 100 HOLD
Tech 31.0 Fund 46.0 Flow 60.0 Mom 50.0
Weinstein Technical Phase Markup · Hold / add on dips
Price above SMA50, rising 50-day trend (8.1% over 20 days), RSI 59
RSI-14: 59.0 · SMA20: $14.81 · SMA50: $13.63

6-Pillar Scorecard Institutional Category Breakdown (WYHG 1 – 5 HLF)

Columns: Metric · WYHG · HLF
1. Valuation Multiples HLF
Forward P/E N/M 5.1x
Trailing P/E 6.8x 9.2x
PEG Ratio N/M 0.61x
EV / Revenue 0.3x 0.6x
2. Growth & Scale HLF
Revenue Growth (YoY) -7.5% +6.0%
Earnings Growth (YoY) +1.7% +31.5%
TTM Revenue (USD) $310M $5.28B
Market Cap $99.3M $1.6B
3. Profitability & Quality HLF
Gross Margin 28.9% 77.6%
Operating Margin 7.8% 9.8%
Net Profit Margin 4.7% 3.4%
Return on Equity (ROE) 3.9% 0.0%
4. Balance Sheet & Cash Flow WYHG
Cash Generation (TTM) $39M EBITDA $337M
Cash Flow Margin 12.7% EBITDA Mgn 6.4%
Net Cash / Leverage $16.53 Book/Sh · 3.9% ROE $1.70B Net Debt
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning HLF
Options Structure Phase UNCLASSIFIED SURGE
Current IV / %ile N/A (N/A) 47.1% (4th %ile)
Put/Call OI Skew Thin ADR Chain 0.23x (Call-Skewed)
OBV Trend / Tech Phase NEUTRAL · Markdown NEUTRAL · Markup
6. R&D & Supply-Chain Moat HLF
OpEx & R&D Intensity 21.1% of Rev ($65M) 67.8% of Rev ($3.58B)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Packaged Foods Operator Packaged Foods Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: WYHG (3) vs HLF (7)
Institutional Metric WYHG HLF Criterion Row Edge
Market Capitalization
Scale
$99.3M $1.6B Larger Scale HLF
Trailing P/E Ratio
Valuation
6.8x 9.2x Lower Multiple WYHG
Forward P/E Ratio
Valuation
N/M 5.1x Lower Multiple HLF
Revenue Growth (YoY)
Growth
-7.5% +6.0% Higher Growth HLF
Operating Margin (TTM)
Profitability
7.8% 9.8% Higher Margin HLF
Net Profit Margin
Profitability
4.7% 3.4% Higher Margin WYHG
Return on Equity (ROE)
Capital Efficiency
3.9% 0.0% Higher ROE WYHG
52-Week Range Position
Momentum
9% ($0–$26) 58% ($9–$20) Stronger Trend HLF
Beta / 30D Volatility
Risk Regime
1.20β · 156% Vol 1.02β · 50% Vol Lower Realized Risk HLF
Unified Institutional Score
Composite Signal
41.6 / 100 (SELL) 47.4 / 100 (HOLD) Higher Composite HLF
Trailing 12M Revenue (USD)
Operating Scale
$310M $5.28B FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
28.9% 77.6% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · 0.3x EV/Rev 0.61x PEG · 0.6x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$39M EBITDA ($16.53 Book/Sh · 3.9% ROE) $337M ($1.70B Net Debt) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon HLF +11.93 pp
WYHG: +0.77% · HLF: +12.7%
3M Horizon HLF +72.58 pp
WYHG: -49.13% · HLF: +23.45%
6M Horizon WYHG +156.21 pp
WYHG: +181.15% · HLF: +24.94%
1Y Horizon WYHG +136.78 pp
WYHG: +205.22% · HLF: +68.44%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on WYHG vs HLF. Trailing 12-month operating profitability (WYHG 7.8% vs HLF 9.8%) and valuation multiples (WYHG N/M vs HLF 5.1x Forward P/E) are benchmarked directly in Pillar 4 below.

WYHG ADR TTM Benchmark FX-Normalized USD
TTM Revenue$310M
Gross Margin28.9%
Op. Margin7.8%
ROE / Fwd P/E3.9% · N/M
HLF ADR TTM Benchmark FX-Normalized USD
TTM Revenue$5.28B
Gross Margin77.6%
Op. Margin9.8%
ROE / Fwd P/E0.0% · 5.1x

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
WYHG UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew Thin ADR Chain
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact WYHG Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
HLF SURGE
5d in phase · OBV NEUTRAL
Current IV 47.1%
IV Percentile 4th %ile
Put/Call OI Skew 0.23x (Call-Skewed)
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow NEUTRAL
Exact HLF Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
WYHG Moat Profile Cyclical / Execution-Driven Positioning
Packaged Foods Operator
Competes within the Packaged Foods value chain with $99.3M market capitalization and 7.8% operating margin.
OpEx & R&D Reinvestment 21.1% of Rev ($65M)
90D Engineering Disclosures 0 Published
HLF Moat Profile Cyclical / Execution-Driven Positioning
Packaged Foods Operator
Competes within the Packaged Foods value chain with $1.6B market capitalization and 9.8% operating margin.
OpEx & R&D Reinvestment 67.8% of Rev ($3.58B)
90D Engineering Disclosures 0 Published

Investor FAQ WYHG vs HLF Key Questions & Quantitative Answers

As of Nov 20, 2026, Herbalife Ltd. (HLF) is the stronger overall head-to-head candidate over Wing Yip Food Holdings Group Limited (WYHG) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). WYHG carries a Unified Composite Score of 41.6/100 (SELL) at $2.62 (N/M Forward P/E, 7.8% operating margin), whereas HLF carries 47.4/100 (HOLD) at $15.53 (5.1x Forward P/E, 9.8% operating margin). Technical & Structure Timing Caution: WYHG is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 40.2); meanwhile HLF trades in a Markup technical trend (SURGE options phase, RSI 59.0). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

HLF leads the Growth & Scale pillar: WYHG posts -7.5% YoY revenue growth and +1.7% YoY earnings growth on $310M TTM revenue (28.9% gross margin, 7.8% operating margin), compared with HLF at +6.0% YoY revenue growth and +31.5% YoY earnings growth on $5.28B TTM revenue (77.6% gross margin, 9.8% operating margin). On trailing 12-month operating scale, WYHG generates $310M in USD-normalized revenue versus $5.28B for HLF. In operating R&D and SG&A reinvestment, WYHG deploys 21.1% of Rev ($65M) (0 90-day corporate R&D disclosures) versus 67.8% of Rev ($3.58B) (0 disclosures) for HLF.

HLF screens cheaper on headline valuation multiples. WYHG trades at N/M Forward P/E, 6.8x Trailing P/E, N/M PEG, and 0.3x EV/Revenue (12.7% EBITDA margin), whereas HLF trades at 5.1x Forward P/E, 9.2x Trailing P/E, 0.61x PEG, and 0.6x EV/Revenue (6.4% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against WYHG (3.9% ROE) versus HLF (0.0% ROE) capital efficiency.

In options market volatility and institutional positioning, WYHG carries N/A implied volatility (N/A, Unclassified), thin ADR options open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.20β · 156% Vol realized risk). By comparison, HLF carries 47.1% implied volatility (4th %ile, Compressed (<25th %ile)), a 0.23x (Call-Skewed) Put/Call open-interest ratio, NEUTRAL on-balance volume, and sits in a SURGE options structure phase (1.02β · 50% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.